Abstract

Topical Treatment of Primary Focal Hyperhidrosis, Part 1

Author(s): Zur Eyal

Issue: Jan/Feb 2019 - Volume 23, Number 1

Page(s): 23-31

Download in electronic PDF format for $75
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Page 1
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Page 2
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Page 3
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Page 4
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Page 5
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Page 6
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Page 7
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Page 8
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Page 9

Abstract

Primary focal hyperhidrosis is idiopathic, localized, uncontrollable, excessive, and unpredictable sweating beyond what is necessary to regulate body temperature. Primary hyperhidrosis is thought to affect approximately 2% to 3% of the population, and its effect on a patient's quality of life is very significant. Primary focal hyperhidrosis can be managed using various therapeutic options, including drugs (topical and systemic), nonsurgical interventions (e.g., iontophoresis, botulinum toxin injections), and surgery. This article, which is presented in 2 parts, is a comprehensive review of the topical, evidence-based treatments of primary focal hyperhidrosis, and it covers the following active pharmaceutical ingredients: aluminum salts, methenamine, glycopyrronium salts, oxybutynin chloride; the latter 2 ingredients will be discussed in part 2 of this article. This article discusses the evidence-based data that exists from clinical trials that support the use of topical medications to treat the pathology from efficacy and from a safety point of view. This review also discusses compounding considerations for professionally and safely compounding various topical preparations. In addition, a range of relevant formulas are attached to the article and can be used by compounding pharmacists.

Related Keywords

  • excessive sweating
  • perspiration
  • exocrine sweat glands
  • patient quality of life
  • anticholinergic agents
  • iontophoresis
  • topical preparations
  • formulations
  • antiperspirants
  • aluminum salts
  • drug safety
  • aluminum chloride hexahydrate
  • salicylic acid
  • contact dermatitis
  • methenamine hippurate
  • deodorants

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • ADVERSE DRUG EVENTS
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2019
Pg. 23-31
Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Author(s): Zur Eyal
Mar/Apr 2019
Pg. 94-104
Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Author(s): Zur Eyal
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Nov/Dec 2020
Pg. 451-458
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jan/Feb 2001
Pg. 28-29
Topical Therapy for Localized Hyperhidrosis
Author(s): Glasnapp Andrew
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Jan/Feb 2017
Pg. 22-27
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Author(s): Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
Jul/Aug 2019
Pg. 351
Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104.
Author(s):
Mar/Apr 2016
Pg. 107-113
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Author(s): Rabi Joseph
Jul/Aug 2002
Pg. 288-292
Basics of Compounding for Iontophoresis, Part II
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 270-274
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Author(s): Riepl Mike
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike
Nov/Dec 2011
Pg. 458-463
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Author(s): Zur Eyal
Nov/Dec 2012
Pg. 462-469
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Author(s): Zur Eyal
Jan/Feb 2013
Pg. 74-85
View Sample
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
May/Jun 2017
Pg. 205-211
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea